AstraZeneca's Tagrisso Secures EU Approval for EGFR-Mutated Locally Advanced NSCLC
CompanyDrug

AstraZeneca’s Tagrisso Secures EU Approval for EGFR-Mutated Locally Advanced NSCLC

Ikena Oncology and Inmagene Biopharmaceuticals to Merge into ImageneBio, Listed on Nasdaq as 'IMA'
CompanyDeals

Ikena Oncology and Inmagene Biopharmaceuticals to Merge into ImageneBio, Listed on Nasdaq as ‘IMA’

Sanofi and SK bioscience Broaden Partnership to Develop Next-Gen Pneumococcal Vaccines
CompanyDeals

Sanofi and SK bioscience Broaden Partnership to Develop Next-Gen Pneumococcal Vaccines

Corxel Pharmaceuticals Secures Global Rights to CX11, a Novel Oral GLP-1 RA, in Licensing Deal with Vincentage
CompanyDeals

Corxel Pharmaceuticals Secures Global Rights to CX11, a Novel Oral GLP-1 RA, in Licensing Deal with Vincentage

ETERN Therapeutics' YAP/TEAD Inhibitor ETS-006 Wins FDA Clinical Approval for Advanced Solid Tumors
CompanyDrug

ETERN Therapeutics’ YAP/TEAD Inhibitor ETS-006 Wins FDA Clinical Approval for Advanced Solid Tumors

Bristol-Myers Squibb's Opdivo-Yervoy Combo Approved by EC for MSI-H/mCRC
CompanyDrug

Bristol-Myers Squibb’s Opdivo-Yervoy Combo Approved by EC for MSI-H/mCRC

Roche's Lunsumio Receives NMPA Approval for R/R Follicular Lymphoma Treatment
CompanyDrug

Roche’s Lunsumio Receives NMPA Approval for R/R Follicular Lymphoma Treatment

BeiGene Rebrands to BeOne Medicines Ltd, Ticker Symbol Changes to 'ONC'
Company

BeiGene Rebrands to BeOne Medicines Ltd, Ticker Symbol Changes to “ONC”

RAPT Therapeutics Secures Ex-China Rights to Jemincare Group's Anti-IgE Antibody JYB1904
CompanyDeals

RAPT Therapeutics Secures Ex-China Rights to Jemincare Group’s Anti-IgE Antibody JYB1904

Porton Pharma and Dragon Sail Join Forces to Enhance ADC Drug Development
CompanyDeals

Porton Pharma and Dragon Sail Join Forces to Enhance ADC Drug Development

GSK's Jemperli Combo Shows Improved PFS in Phase III Ovarian Cancer Trial
CompanyDrug

GSK’s Jemperli Combo Shows Improved PFS in Phase III Ovarian Cancer Trial

Pfizer's Braftovi Receives FDA Approval for Metastatic Colorectal Cancer Treatment
CompanyDrug

Pfizer’s Braftovi Receives FDA Approval for Metastatic Colorectal Cancer Treatment